We are live on ! Find out more
GNPX icon

Genprex

4 hedge funds and large institutions have $7.96M invested in Genprex in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding

Funds holding: 1 → 4 (+3)

6.28% more ownership

Funds ownership: 1.42% → 7.7% (+6.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Sellers

No sellers this quarter

GNPX Hedge Fund Activity: Q2 2018 in Review

4 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2018, worth a combined $7.96M — up 817% from $868K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new GNPX positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $3.53M.

  • 4 institutional investors held Genprex (GNPX) as of Q2 2018, up from 1 in Q1 2018.
  • Funds reported $7.96M of Genprex stock for Q2 2018, up 817% quarter-over-quarter.
  • 3 funds opened new Genprex positions in Q2 2018 and 0 closed out, a net change of +3 holders.
  • The largest Genprex buyer in Q2 2018 was Hudson Bay Capital Management, an estimated $3.53M added.

Based on aggregated 13F filings for Q2 2018.